Insider Trading activities of Colucid Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Colucid Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Colucid Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Colucid Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is CLCD. The reporting company's CIK number is 1348649.
The total value of stock buying since 2005 is $23,053,272.
The total value of stock sales since 2005 is $5,274,888.
The total value of stock option exercises since 2005 is $492,518.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Colucid Pharmaceuticals, Inc. (CLCD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-01 0 $0 6,327 $224,457 6,335 $23,014
2016-12 0 $0 2,245 $78,989 0 $0
2016-11 0 $0 4,083 $117,670 6,336 $23,021
2016-10 0 $0 4,083 $151,747 6,336 $23,021
2016-09 100,000 $2,000,000 61,238 $1,245,964 52,492 $336,180
2016-08 0 $0 156,186 $1,319,940 3,755 $0
2016-07 0 $0 3,026 $28,407 3,755 $0
2016-06 0 $0 3,026 $21,351 3,756 $0
2016-05 0 $0 0 $0 45,064 $0
2016-04 0 $0 299,765 $2,086,363 0 $0
2015-11 0 $0 0 $0 180,254 $0
2015-08 7,500 $53,272 0 $0 0 $0
2015-05 2,100,000 $21,000,000 0 $0 14,145 $64,784
2015-03 0 $0 0 $0 5,528 $22,498

Table 2. Detailed insider stock purchases, sales, and option exercises of Colucid Pharmaceuticals, Inc. insiders (CLCD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-01-05 Mathers Thomas P. (Chief Executive Officer) Sale 1,502 34.90 52,424
2017-01-05 Mathers Thomas P. (Chief Executive Officer) Option Ex 3,755 .00 0
2017-01-05 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 1,677 34.52 57,891
2017-01-05 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 1,677 10.00 16,770
2017-01-04 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 185 36.40 6,734
2017-01-04 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 185 7.56 1,398
2017-01-03 Kuca Bernice (Head,Clin. and Reg. Operations) Sale 772 36.25 27,985
2017-01-03 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 718 36.25 26,027
2017-01-03 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 718 6.75 4,846
2017-01-03 Dallas Matthew D (Chief Financial Officer) Sale 1,473 36.25 53,396
2016-12-01 Kuca Bernice (Head,Clin. and Reg. Operations) Sale 772 35.22 27,189
2016-12-01 Dallas Matthew D (Chief Financial Officer) Sale 1,473 35.17 51,800
2016-11-07 Mathers Thomas P. (Chief Executive Officer) Sale 1,502 28.57 42,916
2016-11-07 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 1,677 28.52 47,829
2016-11-07 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 1,677 10.00 16,770
2016-11-05 Mathers Thomas P. (Chief Executive Officer) Option Ex 3,755 .00 0
2016-11-04 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 185 28.95 5,355
2016-11-04 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 185 7.56 1,398
2016-11-01 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 719 30.00 21,570
2016-11-01 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 719 6.75 4,853
2016-10-05 Mathers Thomas P. (Chief Executive Officer) Sale 1,502 37.08 55,694
2016-10-05 Mathers Thomas P. (Chief Executive Officer) Option Ex 3,755 .00 0
2016-10-05 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 1,677 37.08 62,183
2016-10-05 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 1,677 10.00 16,770
2016-10-04 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 185 36.41 6,735
2016-10-04 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 185 7.56 1,398
2016-10-03 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 719 37.74 27,135
2016-10-03 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 719 6.75 4,853
2016-09-14 Mathers Thomas P. (Chief Executive Officer) Sale 6,000 23.54 141,240
2016-09-09 Novo A/s (10% Owner) Buy 100,000 20.00 2,000,000
2016-09-07 Mathers Thomas P. (Chief Executive Officer) Sale 5,000 22.58 112,899
2016-09-06 Mathers Thomas P. (Chief Executive Officer) Sale 1,502 19.50 29,289
2016-09-06 Hogan Linda C. (Head, Bus. Dev. and Strategy) Sale 48,736 19.75 962,536
2016-09-06 Hogan Linda C. (Head, Bus. Dev. and Strategy) Option Ex 48,736 6.90 336,180
2016-09-05 Mathers Thomas P. (Chief Executive Officer) Option Ex 3,756 .00 0
2016-08-31 Skwierczynski Raymond (Head,Pharmaceutical Operations) Sale 150 10.86 1,629
2016-08-19 Skwierczynski Raymond (Head,Pharmaceutical Operations) Sale 508 8.41 4,272
2016-08-10 Skwierczynski Raymond (Head,Pharmaceutical Operations) Sale 508 8.30 4,216
2016-08-05 Mathers Thomas P. (Chief Executive Officer) Sale 1,502 8.31 12,481
2016-08-05 Mathers Thomas P. (Chief Executive Officer) Option Ex 3,755 .00 0
2016-08-03 Vitullo Nicole (10% Owner) Sale 81,223 8.15 661,967
2016-08-02 Vitullo Nicole (10% Owner) Sale 19,750 8.71 172,021
2016-08-01 Vitullo Nicole (10% Owner) Sale 52,300 8.82 461,285
2016-07-29 Skwierczynski Raymond (Head,Pharmaceutical Operations) Sale 508 9.09 4,615
2016-07-20 Skwierczynski Raymond (Head,Pharmaceutical Operations) Sale 508 8.97 4,556
2016-07-11 Skwierczynski Raymond (Head,Pharmaceutical Operations) Sale 508 9.10 4,622
2016-07-05 Mathers Thomas P. (Chief Executive Officer) Sale 1,502 9.73 14,614
2016-07-05 Mathers Thomas P. (Chief Executive Officer) Option Ex 3,755 .00 0
2016-06-30 Skwierczynski Raymond (Head,Pharmaceutical Operations) Sale 516 7.01 3,617
2016-06-20 Skwierczynski Raymond (Head,Pharmaceutical Operations) Sale 500 7.00 3,500
2016-06-10 Skwierczynski Raymond (Head,Pharmaceutical Operations) Sale 508 6.60 3,351
2016-06-06 Mathers Thomas P. (Chief Executive Officer) Sale 1,502 7.25 10,883
2016-06-05 Mathers Thomas P. (Chief Executive Officer) Option Ex 3,756 .00 0
2016-05-05 Mathers Thomas P. (Chief Executive Officer) Option Ex 45,064 .00 0
2016-04-28 Vitullo Nicole (10% Owner) Sale 150,000 6.96 1,043,999
2015-11-05 Mathers Thomas P. (Chief Executive Officer) Option Ex 180,254 .00 0
2015-08-25 Mathers Thomas P. (Chief Executive Officer) Buy 7,500 7.10 53,272
2015-05-13 Rupniak Nadia (VP-Research and Development) Option Ex 14,145 4.58 64,784
2015-05-11 Tvm Life Science Ventures Vii L.p. (10% Owner) Buy 500,000 10.00 5,000,000
2015-05-11 Novo A/s (10% Owner) Buy 1,300,000 10.00 13,000,000
2015-05-11 A.m. Pappas & Associates, Llc (10% Owner) Buy 300,000 10.00 3,000,000
2015-03-23 A.m. Pappas & Associates, Llc (10% Owner) Option Ex 5,528 4.07 22,498

Insider trading activities including stock purchases, stock sales, and option exercises of CLCD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Colucid Pharmaceuticals, Inc. (symbol CLCD, CIK number 1348649) see the Securities and Exchange Commission (SEC) website.